Angelina Marr

1.1k total citations · 1 hit paper
11 papers, 736 citations indexed

About

Angelina Marr is a scholar working on Neurology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Angelina Marr has authored 11 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 2 papers in Pathology and Forensic Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Angelina Marr's work include Intracranial Aneurysms: Treatment and Complications (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers) and Vascular Malformations Diagnosis and Treatment (4 papers). Angelina Marr is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers) and Vascular Malformations Diagnosis and Treatment (4 papers). Angelina Marr collaborates with scholars based in United States, Switzerland and Canada. Angelina Marr's co-authors include Sébastiên Roux, Stephan A. Mayer, Randall T. Higashida, Isabel Wanke, Peter Vajkoczy, R. Loch Macdonald, Andy Molyneux, Neal F. Kassell, Aline Frey and Andreas Raabe and has published in prestigious journals such as JAMA, Stroke and The Lancet Neurology.

In The Last Decade

Angelina Marr

11 papers receiving 723 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

2011 453 citations R. Loch Macdonald, Randall T. Higashida et al. The Lancet Neurology profile →

Peers

Countries citing papers authored by Angelina Marr

Since Specialization

Citations

This map shows the geographic impact of Angelina Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelina Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelina Marr more than expected).

Fields of papers citing papers by Angelina Marr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelina Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelina Marr. The network helps show where Angelina Marr may publish in the future.

Co-authorship network of co-authors of Angelina Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Angelina Marr. A scholar is included among the top collaborators of Angelina Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelina Marr. Angelina Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage 2022 ·BMC Neurology ·Nicolas Bruder, Randall T. Higashida, Hugues Santin‐Janin, Cécile Dubois, E. François Aldrich, Angelina Marr, Sébastiên Roux, Stephan A. Mayer	15
2	Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage 2020 ·Journal of neurosurgery ·E. François Aldrich, Randall T. Higashida, Abdel Hmissi, Elizabeth Le, R. Loch Macdonald, Angelina Marr, Stephan A. Mayer, Sébastiên Roux, Nicolas Bruder	13
3	Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study 2019 ·World Neurosurgery ·Randall T. Higashida, Nicolas Bruder, (unknown), Raphaël Guzman, Abdel Hmissi, Angelina Marr, Stephan A. Mayer, Sébastiên Roux, Stefan Weidauer, E. François Aldrich	13
4	Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage 2019 ·Stroke ·Stephan A. Mayer, E. François Aldrich, Nicolas Bruder, Abdel Hmissi, R. Loch Macdonald, Tanuwong Viarasilpa, Angelina Marr, Sébastiên Roux, Randall T. Higashida	16
5	Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis 2016 ·JAMA ·Dinesh Khanna, Christopher P. Denton, Peter A. Merkel, Thomas Krieg, Franck‐Olivier Le Brun, Angelina Marr, Kelly Papadakis, Janet Pope, Marco Matucci‐Cerinic, Daniel E. Furst, (unknown)	84
6	Randomised Trial of Clazosentan, an Endothelin Receptor Antagonist, in Patients with Aneurysmal Subarachnoid Hemorrhage Undergoing Surgical Clipping (CONSCIOUS-2) 2012 ·Acta neurochirurgica. Supplementum ·R. Loch Macdonald, Randall T. Higashida, E. Keller, Stephan A. Mayer, Andy Molyneux, Andreas Raabe, Peter Vajkoczy, Isabel Wanke, Doris Bach, Aline Frey, Angelina Marr, Sébastiên Roux, Neal F. Kassell	56
7	Clazosentan for patients with subarachnoid haemorrhage: lessons learned – Authors' reply 2011 ·The Lancet Neurology ·R. Loch Macdonald, Randall T. Higashida, E. Keller, Stephan A. Mayer, Andy Molyneux, Andreas Raabe, Peter Vajkoczy, Isabel Wanke, Doris Bach, Aline Frey, Angelina Marr, Sébastiên Roux, Neal F. Kassell	1
8	Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) breakdown → 2011 ·The Lancet Neurology ·R. Loch Macdonald, Randall T. Higashida, E. Keller, Stephan A. Mayer, Andy Molyneux, Andreas Raabe, Peter Vajkoczy, Isabel Wanke, Doris Bach, Aline Frey, Angelina Marr, Sébastiên Roux, Neal F. Kassell	453
9	Preventing Vasospasm Improves Outcome After Aneurysmal Subarachnoid Hemorrhage: Rationale and Design of CONSCIOUS-2 and CONSCIOUS-3 Trials 2010 ·Neurocritical Care ·R. Loch Macdonald, Randall T. Higashida, E. Keller, Stephan A. Mayer, Andy Molyneux, Andreas Raabe, Peter Vajkoczy, Isabel Wanke, Aline Frey, Angelina Marr, Sébastiên Roux, Neal F. Kassell	48
10	Cancer survival among adolescents in France 2006 ·European Journal of Cancer ·Emmanuel Désandes, Brigitte Lacour, Danièle Sommelet, Arlette Danzon, Patricia Delafosse, Pascale Grosclaude, Josette Macé-Lesec’h, Nabil Maarouf, Angelina Marr, (unknown), Brigitte Trétarre, Michel Velten, Laurence Brugières	23
11	Cancer adolescent pathway in France between 1988 and 1997 2006 ·European Journal of Oncology Nursing ·Emmanuel Désandes, Brigitte Lacour, Danièle Sommelet, Mélanie White‐Koning, Michel Velten, Brigitte Trétarre, Angelina Marr, Nabil Maarouf, Anne‐Valérie Guizard, Patricia Delafosse, Arlette Danzon, (unknown), Laurence Brugières	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact